Tetralogy of fallot overview

Tetralogy of fallot Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Tetalogy of Fallot from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
ACC/AHA Guidelines for Evaluation and Follow-up
Tetralogy of fallot overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tetralogy of fallot overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tetralogy of fallot overview
CDC on Tetralogy of fallot overview
Tetralogy of fallot overview in the news
Blogs on Tetralogy of fallot overview
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tetralogy of fallot overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editors-In-Chief: Keri Shafer, M.D. [2]; Atif Mohammad, M.D., Priyamvada Singh, MBBS

Overview

• Tetralogy of Fallot is a congenital heart defect which classically has four anatomical components.

• Its incidence is approximately 10% of all forms of congenital heart disease.

• It is the commonest cause of cyanotic in children over one year of age blue baby syndrome.

• It was described in 1672 by Niels Stensen and in 1888 by the French physician Etienne Fallot, for whom it is named.

Template:WikiDoc Sources